BioEquity Europe has become a magnet for financial and pharmaceutical company dealmakers, and is the premier venue for biopharma companies looking to attract capital and expand their business development efforts. The 2011 conference will offer an unparalleled showcase of investment opportunities at a critical time for the life sciences.
WilmerHale Partners Joe Pillman and Rüdiger Herrmann and counsel Marcus Pickel will all be featured speakers at this event.
We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.
